Welcome to LookChem.com Sign In|Join Free
  • or
(2-(4-methoxyphenyl)quinolin-4-yl)methanol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

863116-72-7

Post Buying Request

863116-72-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

863116-72-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 863116-72-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,3,1,1 and 6 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 863116-72:
(8*8)+(7*6)+(6*3)+(5*1)+(4*1)+(3*6)+(2*7)+(1*2)=167
167 % 10 = 7
So 863116-72-7 is a valid CAS Registry Number.

863116-72-7Relevant academic research and scientific papers

Design, synthesis and biological evaluation of 4-(Imidazolylmethyl)-2-aryl-quinoline derivatives as aromatase inhibitors and anti-breast cancer agents

Ghodsi, Razieh,Azizi, Ebrahim,Ferlin, Maria Grazia,Pezzi, Vincenzo,Zarghi, Afshin

, p. 89 - 97 (2016)

Some new quinoline derivatives were designed and synthesized to evaluate their biological activities as aromatase inhibitors and anti-breast cancer agents. Cytotoxicity of quinolines 8a-g against human breast cancer MCF-7 and T47D cell lines were evaluate

Design, synthesis and biological evaluation of 4-(imidazolylmethyl)-2-aryl-quinoline derivatives as aromatase inhibitors and anti-breast cancer agents

Ghodsi, Razieh,Azizi, Ebrahim,Ferlin, Maria Grazia,Pezzi, Vincenzo,Zarghi, Afshin

, p. 89 - 97 (2015/12/01)

Some new quinoline derivatives were designed and synthesized to evaluate their biological activities as aromatase inhibitors and anti-breast cancer agents. Cytotoxicity of quinolines 8a-g against human breast cancer MCF-7 and T47D cell lines were evaluate

SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS TNF INHIBITORS

-

Page/Page column 21, (2008/06/13)

The present invention relates to novel compounds of formula (1) and their pharmaceutically useful compositions as MMP and TNF inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 863116-72-7